how are people affording glp 1 GLP-1 Clinical Guidance vs Patient Behavior The GLP-1 Access Gap: Mapping

Data Availability Statement This is a review article and does not include any original data.

Campbell JE

FOR CHRONIC KIDNEY DISEASE SOURCE: National Kidney Foundation

We found here that agonist trafficking properties, as well as insulin secretion, mirrored -arrestin recruitment propensity, contrasting with some 14,33 (but not all 34 ) previous work suggesting that -arrestins do not impact GLP-1R trafficking 14,34,35 , as well as reports of coupling of GLP-1R to insulin secretion via -arrestin-1 14 (although not -arrestin-2 60 )

As a result, patient protection varies widely from prescriber to prescriber, and manufacturer to manufacturer